Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by Vinny57on Oct 26, 2018 8:49pm
203 Views
Post# 28881133

"Thing will no doubt turn around".........Fingers crossed

"Thing will no doubt turn around".........Fingers crossed

Marijuana Market: Aphria (TSX:APH) Looks for Up-Listing to NYSE

Aphria is looking to up-list its stock to the New York Stock Exchange. This would mean it would join Canada’s three other biggest marijuana producers on a major US exchange. Canopy Growth (NYSE:CGC) and Aurora Cannabis (NYSE:ACB) both already trade on the NYSE.

According to Aphria CEO Vic Neufeld, the company is starting fiscal 2019 in a strong position: 

“We advanced the build-out of our expansion in Leamington, signed coast-to-coast supply agreements, launched our strong portfolio of adult-use brands, and created strategic collaborations with leading companies like Perennial that will ensure Aphria continues to lead the consumer experience as the cannabis industry evolves.”

Despite its position, Aphria is in the red today. At the time of writing, it is down 2.10% and selling for $15.88 CAD. However, you can’t keep a good thing down for long. With an encouraging new report and a potential up-listing on the horizon, things will no doubt turn around for Aphria in the marijuana market.

 
Bullboard Posts